title: Successful treatment with adapalene of cetuximab-induced acneiform eruptions.
authors.forename: Kumiko
authors.initials: K
authors.lastname: Taguchi
authors.forename: Atsushi
authors.initials: A
authors.lastname: Fukunaga
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Okuno
authors.forename: Chikako
authors.initials: C
authors.lastname: Nishigori
mesh_terms: D017486:Acneiform Eruptions / Q000188:drug therapy* / Q000209:etiology*; D000068816:Adapalene; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects; D000068818:Cetuximab; D003879:Dermatologic Agents / Q000627:therapeutic use; D003875:Drug Eruptions / Q000188:drug therapy* / Q000209:etiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D009281:Naphthalenes; D000068816:Adapalene; D066246:ErbB Receptors; D000068818:Cetuximab